DALLAS & LUBBOCK, TEXAS–(BUSINESS WIRE)–Dallas-based Panda Biotech today announced it is developing its first industrial hemp processing facility to produce high-quality, textile-grade fiber and premium cellulose. The “Panda High Plains Hemp Gin,” to be located in Lubbock County, Texas, is expected to be the largest hemp decortication center in the United States and one of…
DetailsSEATTLE–(BUSINESS WIRE)–Leafly, the world’s leading cannabis information resource, today launched Leafly Market, an online store with the largest selection of hemp-derived CBD products independently tested for cannabinoid potency, pesticides and heavy metals. Building on Leafly’s expertise in cannabis information and education, Leafly Market provides tested products, education and a simple shopping experience so people can…
DetailsSEATTLE–(BUSINESS WIRE)–Leafly, the world’s leading cannabis resource, today announced Leafly Insights, a data analysis tool that helps cannabis retailers understand local market data so that they can better navigate a competitive market. Available through the Leafly Business Portal, Leafly Insights analyzes local cannabis trends and allows for store-to-store and menu-to-menu comparisons of cannabis products and…
DetailsSEATTLE–(BUSINESS WIRE)–Leafly, the world’s leading cannabis resource, today announced a strategic partnership with the American Medical Marijuana Physicians Association (AMMPA), the world’s largest physician-based cannabis association, to empower doctors to provide cannabis-based care to patients and better connect patients with licensed cannabis physicians. The partnership reflects the rise in demand for cannabinoid medicine as 33…
DetailsLOS ANGELES–(BUSINESS WIRE)–Ocean Grown Ventures (the “Company”), a science-focused cannabis company offering wellness solutions that meet pharmaceutical manufacturing standards, today announced the launch of ‘Tikva’, a full-spectrum hemp-derived CBD product line, designed to provide consumers consistent and high quality health and wellness offerings. Tikva – derived from the Hebrew word for ‘hope’ – offers formulations…
DetailsNEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced the addition of Jesse Channon as the Company’s first chief growth officer. In his new role, Mr.…
DetailsSASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) is pleased to announce that effective December 6, 2019, it received a “3 year” Standard Processing Licence from Health Canada for its Saskatoon-based Phase I processing facility (the “Processing Licence”). The Processing Licence allows ZYUS to handle and extract dried cannabis into cannabis oil, to…
DetailsDUBLIN–(BUSINESS WIRE)–The “World Clinical Chemistry Analyzers and Reagents Market in the Americas, EMEA, APAC: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review” report has been added to ResearchAndMarkets.com’s offering. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and…
DetailsSAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a fourth quarter 2019 dividend of $1.00 per share of common stock, representing an approximately 28% increase…
DetailsCHICAGO–(BUSINESS WIRE)–Amplify ETFs announces the net asset value (NAV) of the Amplify Seymour Cannabis ETF (NYSE Arca: CNBS) was reduced by $0.2562 per share on Friday, December 6, 2019. This adjustment is a result of an error in calculating the Fund’s NAV. Fund Ticker Revised NAV (12/6/2019) Original NAV (12/6/2019) Change…
DetailsNEW YORK–(BUSINESS WIRE)–UBS AG announced today that it has commenced exchange offers (“Exchange Offers”) for eight ETRACS Series A ETNs (collectively, the “Series A ETNs”) for corresponding ETRACS Series B ETNs (collectively, the “Series B ETNs”), as set forth in Table-1 below. The full schedule of exchange dates and exchange offer settlement dates is listed…
DetailsDUBLIN–(BUSINESS WIRE)–The “Dyskinesia – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape. The review provides comprehensive information on the therapeutics under development for Dyskinesia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of…
Details